Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Intellectual disability and Global developmental delay; and very common findings: Motor delay and Delayed speech and language development. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Seizure, Aggressive behavior, Anxiety |
TRIP12 function has not been fully characterized.
Clark-Baraitser syndrome is associated with mutations in the TRIP12 gene on chromosome 2.
Genetic testing for TRIP12 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 2 very common features, 8 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
27 publications have been identified in PubMed for Clark-Baraitser syndrome. Research spans Case Report / Case Series (44%), Review / Meta-Analysis (22%), and Basic Science / Preclinical (22%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 44% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 2:47 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Clark-Baraitser syndrome
Head and neck
3 |
Thin upper lip vermilion, High palate, Microcephaly |
Eyes | 1 | Strabismus |
Muscles | 1 | Low muscle tone (hypotonia) |
Research summaries |
6 |
22% |
Laboratory research | 6 | 22% |
Disease patterns and progression | 3 | 11% |
Sundman AK (2026). [PMID: 40986435](https://pubmed.ncbi.nlm.nih.gov/40986435/). *Brain*. [Review / Meta-Analysis]
van der Laan L (2026). [PMID: 42068851](https://pubmed.ncbi.nlm.nih.gov/42068851/). *Stem Cell Res*. [Basic Science / Preclinical]
Parisi MA (2026). [PMID: 41883813](https://pubmed.ncbi.nlm.nih.gov/41883813/). *Ther Adv Rare Dis*. [Review / Meta-Analysis]
Bernert A (2026). [PMID: 41656275](https://pubmed.ncbi.nlm.nih.gov/41656275/). *Mol Brain*. [Basic Science / Preclinical]
Alyahya YA (2026). [PMID: 41497020](https://pubmed.ncbi.nlm.nih.gov/41497020/). *Ann Med Surg (Lond)*. [Case Report / Case Series]
Margiotti K (2025). [PMID: 41465129](https://pubmed.ncbi.nlm.nih.gov/41465129/). *Genes (Basel)*. [Case Report / Case Series]
Du H (2025). [PMID: 40062706](https://pubmed.ncbi.nlm.nih.gov/40062706/). *Am J Med Genet A*. [Case Report / Case Series]
Nobakht R (2025). [PMID: 40172777](https://pubmed.ncbi.nlm.nih.gov/40172777/). *J Mol Neurosci*. [Case Report / Case Series]
Moreno BA (2025). [PMID: 40881542](https://pubmed.ncbi.nlm.nih.gov/40881542/). *Cureus*. [Case Report / Case Series]
Do NM (2025). [PMID: 40604848](https://pubmed.ncbi.nlm.nih.gov/40604848/). *BMC Oral Health*. [Case Report / Case Series]